Department for Health, University of Bath, Bath, BA2 7AY, UK.
Department of Physical Education, National Taiwan Normal University, Taipei, Taiwan.
Eur J Nutr. 2020 Sep;59(6):2449-2462. doi: 10.1007/s00394-019-02092-4. Epub 2019 Sep 17.
To examine whether calcium type and co-ingestion with protein alter gut hormone availability.
Healthy adults aged 26 ± 7 years (mean ± SD) completed three randomized, double-blind, crossover studies. In all studies, arterialized blood was sampled postprandially over 120 min to determine GLP-1, GIP and PYY responses, alongside appetite ratings, energy expenditure and blood pressure. In study 1 (n = 20), three treatments matched for total calcium content (1058 mg) were compared: calcium citrate (CALCITR); milk minerals rich in calcium (MILK MINERALS); and milk minerals rich in calcium plus co-ingestion of 50 g whey protein hydrolysate (MILK MINERALS + PROTEIN). In study 2 (n = 6), 50 g whey protein hydrolysate (PROTEIN) was compared to MILK MINERALS + PROTEIN. In study 3 (n = 6), MILK MINERALS was compared to the vehicle of ingestion (water plus sucralose; CONTROL).
MILK MINERALS + PROTEIN increased GLP-1 incremental area under the curve (iAUC) by ~ ninefold (43.7 ± 11.1 pmol L 120 min; p < 0.001) versus both CALCITR and MILK MINERALS, with no difference detected between CALCITR (6.6 ± 3.7 pmol L 120 min) and MILK MINERALS (5.3 ± 3.5 pmol L 120 min; p > 0.999). MILK MINERALS + PROTEIN produced a GLP-1 iAUC ~ 25% greater than PROTEIN (p = 0.024; mean difference: 9.1 ± 6.9 pmol L 120 min), whereas the difference between MILK MINERALS versus CONTROL was small and non-significant (p = 0.098; mean difference: 4.2 ± 5.1 pmol L 120 min).
When ingested alone, milk minerals rich in calcium do not increase GLP-1 secretion compared to calcium citrate. Co-ingesting high-dose whey protein hydrolysate with milk minerals rich in calcium increases postprandial GLP-1 concentrations to some of the highest physiological levels ever reported. Registered at ClinicalTrials.gov: NCT03232034, NCT03370484, NCT03370497.
研究钙的类型和与蛋白质共摄入是否会改变肠道激素的可用性。
年龄在 26±7 岁(平均值±标准差)的健康成年人完成了三项随机、双盲、交叉研究。在所有研究中,在餐后 120 分钟内采集动脉化血液样本,以确定 GLP-1、GIP 和 PYY 反应以及食欲评分、能量消耗和血压。在研究 1(n=20)中,三种治疗方法的总钙含量(1058mg)相同:柠檬酸钙(CALCITR);富含钙的牛奶矿物质(MILK MINERALS);和富含钙的牛奶矿物质加上共摄入 50g 乳清蛋白水解物(MILK MINERALS+PROTEIN)。在研究 2(n=6)中,将 50g 乳清蛋白水解物(PROTEIN)与 MILK MINERALS+PROTEIN 进行比较。在研究 3(n=6)中,将 MILK MINERALS 与摄入的载体(水加蔗糖素;CONTROL)进行比较。
MILK MINERALS+PROTEIN 使 GLP-1 增量曲线下面积(iAUC)增加了约九倍(43.7±11.1pmol L 120 min;p<0.001),与 CALCITR 和 MILK MINERALS 相比,而 CALCITR(6.6±3.7pmol L 120 min)和 MILK MINERALS(5.3±3.5pmol L 120 min)之间没有差异;p>0.999)。MILK MINERALS+PROTEIN 产生的 GLP-1 iAUC 比 PROTEIN 高约 25%(p=0.024;平均差异:9.1±6.9pmol L 120 min),而 MILK MINERALS 与 CONTROL 之间的差异较小且无统计学意义(p=0.098;平均差异:4.2±5.1pmol L 120 min)。
单独摄入富含钙的牛奶矿物质与柠檬酸钙相比不会增加 GLP-1 分泌。与富含钙的牛奶矿物质共摄入高剂量乳清蛋白水解物可使餐后 GLP-1 浓度增加到迄今为止报道的最高生理水平之一。在 ClinicalTrials.gov 注册:NCT03232034、NCT03370484、NCT03370497。